Biotech Week back issues from October 2004:
FDA approval sought for AbioCor replacement heart.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Abiomed, Inc., (ABMD) announced that the company has submitted, pending acceptance for filing, to the U.S. Food and Drug Administration (FDA) for market approval the AbioCor Implantable Replacement Heart under a Humanitarian Device Exemption (HDE) ....
FDA approves Methylin Chewable Tablets, Methylin Oral Solution for ADHD.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Alliant Pharmaceuticals, Inc., announced U.S. Food and Drug Administration (FDA) approval of Methylin Chewable Tablets and Methylin Oral Solution for the treatment of ADHD. The two products are the first, and only, chewable tablet and ...
Crestor reaches 10M prescription milestone.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- AstraZeneca announced that Crestor (rosuvastatin), its statin indicated for the treatment of dyslipidemia, has reached the significant milestone of 10 million prescriptions worldwide. Crestor is now approved in 64 countries worldwide and ...
Wireless care improves monitoring of elderly and disabled people.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- In the past, old age or disabilities have often implied a loss of independence, as elderly and disabled people find themselves reliant on family members and carers to look after them. That situation may change, thanks to a location-aware mobile ...
Excess GM1-ganglioside in brain cells triggers neurodegeneration, retardation.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Excess accumulation in brain cells of a fat molecule called GM1-ganglioside (GM1) disrupts the folding of newly assembled proteins into their proper shapes, triggering nerve degeneration and mental retardation in children. This finding, ...
Consistency of treatment for external genital warts is variable in the U.K.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- The consistency of treatment for external genital warts is variable in the United Kingdom. According to recent research from the United States, "Our objective was to identify patterns of treatment and resources used in achieving complete ...
Additional drug discovery deal with Synaptic signed.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- 7TM Pharma announced that 7TM Pharma and Synaptic, a wholly owned subsidiary of Lundbeck, have signed a new collaborative research agreement again focused on 7TM Pharma's drug discovery approach. Under the agreement, 7TM will apply its ...
First lady of Zambia dedicates new AIDS treatment clinic in Chikankata, Zambia.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Mrs. Maureen Mwanawasa, the first lady of Zambia, officially launched and dedicated the Salvation Army-AIDS Healthcare Foundation-Global Immunity Muka Buumi ("Mother of Life" in Tonga) anti-retroviral therapy (ART) clinic on September 1 at the ...
Nutritional supplements company reports a 34% increase in customers.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- AMS Health Sciences, Inc., (AMM, AMS) announced August month-end results of its new customer acquisition program, totaling 8751 new associates and preferred customers, averaging $60 per monthly recurring order. New sales associate ...
Enteroviral meningitis outbreak in France is caused by human echovirus 30.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- An enteroviral meningitis outbreak in France is caused by human echovirus 30. According to recent research from France, "Enteroviruses (EVs) are responsible for an array of clinical diseases affecting different systems of the organism ....
Pharmaceutical firm secures seed funding of $1.6M.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- APT Therapeutics, Inc., announced that it has recently secured seed funding of $1.6 million from two venture capital firms: Prolog Ventures (St. Louis) and CID Equity Partners (Indianapolis). With this seed funding, APT Therapeutics will ...
Paper describes new treatment for prevention of postsurgical adhesions.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- ARC Pharmaceuticals, Inc., announced that Dr. Johanne Cashman, director of preclinical research, published a paper entitled "Camptothecin-loaded Films for the Prevention of Postsurgical Adhesions" in the August 2004 issue of Inflammation Research. ...
ELVIS plate method is effective in detecting and typing herpes simplex.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Study finds that a commercial enzyme-linked viral inducible system (ELVIS) is a reliable alternative to shell vial culture (SVC) for rapid detection and typing of herpes simplex virus (HSV). "This study was conducted to assess the ...
Antisense approach to transplant acceptance works by regulating lymphocytes.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- AVI BioPharma, Inc., (AVII) announced that it presented data on its Neugene antisense approach to transplant acceptance at the 20th International Congress of the Transplantation Society, held in Vienna, Austria, Sept. 5-10, 2004. The ...
Freestyle Mini, Precision Xceed blood glucose monitors launched in Europe.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories introduced the FreeStyle Mini and Precision Xceed blood glucose monitoring systems for Europe at the 40th Annual Meeting of the European Association for the Study of Diabetes in Munich, Germany. The FreeStyle system ...
Fully automated test for Hepatitis A virus released.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories introduced its second fully automated hepatitis A test in the United States for its widely used AxSYM automated immunoassay instrument system. Used to aid in the laboratory diagnosis of previous or ongoing hepatitis ...
Pharmaceutical firm appoints H. Ward Wolff as chief financial officer.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Abgenix, Inc., (ABGX) announced the appointment of H. Ward Wolff as chief financial officer and Senior VP, Finance, effective September 13. "Ward brings more than 25 years of finance, operating and management experience to Abgenix at an ...
Generic pharmaceutical firm announces management appointments.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Able Laboratories, Inc., (ABRX) announced the appointments of Joan Janulis - VP, regulatory affairs, and Janet E. Penner - VP, sales and marketing. Janulis has more than 17 years of experience in the area of generic pharmaceutical ...
Prize for modern nutrition from the Federation of Swiss Milk Producers awarded.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Dr. David McCarron, president of Academic Network LLC and visiting professor at the Department of Nutrition at University California Davis, was awarded the 2004 International Prize for Modern Nutrition Since 1967, the Federation of the ...
Genetics of variations of Yersinia pestis biovars presented.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Researchers report the genetics of metabolic variations between Yersinia pestis biovars and propose a new biovar, microtus. "Yersinia pestis has been historically divided into three biovars: antiqua, mediaevalis, and orientalis. On the ...
Study shows ACP-103 improves clinical profile of haloperidol treatment.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Acadia Pharmaceuticals, Inc., (ACAD), a biopharmaceutical company utilizing innovative science to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, reported results from a clinical study that ...
Life sciences IT firm appoints new VP of marketing.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Accelrys, Inc., (ACCL) announced that R. William (Bill) Taylor joined the company as vice president, marketing. Taylor brings more than 20 years of experience in the high-technology field, including over 8 years of marketing and sales ...
Pharmaceutical firm to license Accelrys software.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Accelrys, Inc., (ACCL) announced an agreement with Bayer Healthcare AG under which Bayer has licensed a comprehensive library of life science modeling software from Accelrys. These tools, which will be applied at Bayer's research centers ...
Pharmaceutical firm reports best year ever for sales, profits.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Aceto Corporation (ACET), a global distributor of chemically derived pharmaceuticals, biopharmaceuticals, specialty chemicals and agrochemicals, announced record results of operations for the fourth quarter and fiscal year ended June 30, 2004. ...
Pharmaceutical firm reports fourth quarter net income up 36%.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Aceto Corporation (ACET) announced record results of operations for the fourth quarter and fiscal year ended June 30, 2004. Fourth quarter financial highlights include: 1) net sales grew 12% to $76.5 million; 2) ...
Pharmaceutical firm elects Sandra Fenwick to board of directors.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Acusphere, Inc., (ACUS), a specialty pharmaceutical company that develops drug products using its proprietary porous microparticle technology, announced that Sandra L. Fenwick has been elected to the company's board of directors. ...
Oncology company names chief medical officer.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Adherex Technologies, Inc., (AHX), a biopharmaceutical company with a broad portfolio of clinical oncology products under development, announced that Rajesh K. Malik has joined the company as its chief medical officer. Malik, who brings ...
FDA accepts Entereg (alvimopan) NDA for review.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Adolor Corp. (ADLR) and GlaxoSmithKline (GSK) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the new drug application (NDA) for Entereg (alvimopan) capsules. Adolor completed the submission of the NDA ...
Medical device company named to list of 100 fastest-growing companies.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Advanced Neuromodulation Systems, Inc., (ANS, ANSI) was recently ranked 22nd on Fortune magazine's 16th annual list of 100 Fastest-Growing Companies. "ANS is honored to appear on such a prestigious list. To position the company for ...
FDA conditional approval granted to use Petal Stent System in BOSS trial.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Advanced Stent Technologies (AST), Inc., received U.S. Food & Drug Administration (FDA) conditional approval to incorporate its bare metal novel Petal coronary bifurcation stent and delivery system into its ongoing U.S. BOSS clinical trial on ...
Successful pre-IND meeting for AVR118 with FDA reported.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced that the company had a successful pre-investigational new drug (IND) meeting with the U.S. Food & Drug Administration (FDA) at the end of August. Based on the results of the meeting, ...
Biopharmaceutical firm board of directors appoints Evan Levine president, CEO.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Adventrx Pharmaceuticals, Inc., (ANX) announced that the board of directors appointed Evan M. Levine to serve as president and CEO effective September 4, 2004, to fill the place of Nicholas J. Virca who resigned from his positions effective ...
IND allowed for ALS treatment.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Aeolus Pharmaceuticals, Inc., (AOLS) announced that it has been notified by the U.S. Food and Drug Administration (FDA) of their allowance of Aeolus' Investigational New Drug application (IND) to begin phase I clinical trials of AEOL 10150 for the ...
Hand-held device measures airway inflammation.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Clinical data on a new first-of-a-kind hand-held analyser of inflammation in asthma patients, Niox Mino, were presented for the first time on September 5, 2004, at the European Respiratory Society (ERS) meeting, in Glasgow, Scotland. ...
New linear RNA amplification protocol works with very small samples.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Affymetrix Inc.'s high-density oligonucleotide microarray analysis protocol that includes a linear amplification step has use in situations where RNA recovery is very low, pathologists report. "High-density oligonucleotide microarray ...
Non-sexual household exposures spawn hepatitis C virus clusters in Pakistan.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Non-sexual household exposures spawn hepatitis C virus clusters in Pakistan. According to recent research from Pakistan, "transmission rates of hepatitis C virus (HCV) infection through non-sexual household contacts have been considered ...
Genomics company expands, relocates to new facility.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Agencourt Bioscience Corporation, a provider of genomic services and nucleic acid purification products to the life sciences industry, celebrated the grand opening of its new corporate headquarters in Beverly, Massachusetts. ...
PUVA therapy-induced lentigine development reported.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Extensive psoralen plus ultraviolet A (PUVA) irradiation therapy may induce lentigine development in vitiligo patients. PUVA therapy is "commonly used for the management of vitiligo, in which perifollicular repigmentation is the usual ...
Rat study suggests L-leucine, taken orally during pregnancy, doesn't harm fetus.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- A study conducted in pregnant rats indicates that L-leucine, taken orally, doesn't affect pregnancy outcome and doesn't harm the fetus. "L-Leucine, an essential amino acid, is one of the most popular ingredients in dietary supplements ....
Tumor-specific gene therapy targets uterine cervical cancer.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Tumor-specific gene therapy targets uterine cervical cancer. According to published research from South Korea, "although gene therapies using tissue-specific promoters have been reported to be a promising tool for treating cancers, few ...
Agent-based analysis of smallpox preparedness performed.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Researchers have performed an agent-based analysis of smallpox preparedness and response policy. According to recent research published in the JASSS - the Journal of Artificial Societies and Social Simulation, "Because conjectural ...
Shiga toxin 1-neutralizing Fab fragment isolated.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- A Shiga toxin (Stx)-neutralizing Fab fragment has been isolated and characterized. Stx-producing E. coli (STEC) "causes bloody diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome," scientists in Japan explained. "Molecular ...
Pharmaceutical firm names new VP, global quality and regulatory compliance.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Akorn, Inc., (AKRN.OB) announced the appointment of Marshall L. Goodwin as VP, Global Quality and Regulatory Compliance. Goodwin has more than 25 years of quality assurance and operations management experience in pharmaceuticals and ...
Calcium-free products bind phosphate without cardiovascular calcification.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- A new report describes the challenges and trends in calcium and phosphorus management in chronic kidney disease. According to the report from the United States, "Common and serious comorbidities in chronic kidney disease include bone and ...
DNA binding to viral enzyme may serve as new target for antiviral drugs.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Scientists at the U.S. Department of Energy's Brookhaven National Laboratory and the Albert Einstein College of Medicine have produced the first molecular-scale images of DNA binding to an adenovirus enzyme - a step they believe is essential for ...
Hypothalamic responses to long-chain fatty acids are nutritionally regulated.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Hypothalamic responses to long-chain fatty acids are nutritionally regulated. According to recent research from the United States, "Central administration of the long-chain fatty acid oleic acid inhibits food intake and glucose ...
Linkage between chromosome 21q22 and bipolar disorder points to allele 2.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Linkage between chromosome 21q22 and bipolar disorder points to allele 2. "Linkage analysis has shown that chromosome 21q22 may contain a candidate gene for bipolar disorder (BPD). One potential 21q22 candidate gene we previously ...
Biotech firm's shares to trade on NASDAQ SmallCap market.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Alfacell Corporation (ACEL), a biopharmaceutical company focused on the discovery, development and commercialization of ribonucleases for anti-cancer and other therapeutic applications, announced that The Nasdaq Stock Market, Inc., has approved the ...
Antisense repression of p53 raises cancer cell chemosensitivity.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Antisense repression of p53 raises cancer cell chemosensitivity. "Most gene therapy strategies related to p53 concentrate on the restoration of the activity of mutant p53, as several observations indicate that tumors and cell lines ...
Research shows almonds increase intake of several important nutrients.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- According to researchers at Loma Linda University in California, when individuals added almonds as a snack to their regular diet, their overall intake of several important nutrients increased. The findings indicate that incorporating ...
TheraCLEC selected for FDA's Continuous Marketing Application Pilot 2 program.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Altus Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) has selected TheraCLEC for participation in the Continuous Marketing Application (CMA) Pilot 2 program. ...
Group applauds House passage of memory screening proposal.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- The Alzheimer's Foundation of America (AFA) applauded passage by the U.S. House of Representatives of a proposal advanced by AFA to promote memory screenings as a tool that drives early diagnosis and treatment of Alzheimer disease and related ...
Request submitted to FDA for designated new animal drug listing.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Amarillo Biosciences, Inc., (AMAR) announced that it has submitted requests to the U.S. Food & Drug Administration's (FDA) Office of Minor Use and Minor Species Animal Drug Development (MUMS) for listing as a Designated New Animal Drug for the ...
Update given on ICS technology development.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Sydney-based Ambri Limited (ABI) announced that its international strategic alliance partner Biosensor Enterprises LLC (BEL), a joint venture of Dow Corning Corporation and Genencor International, has demonstrated significant improvements to the ...
Acquisition of Chinese state-owned pharmaceutical company completed.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- America Oriental Bioengineering, Inc., (AOBO) announced the successful completion of its acquisition of Heilongjiang Songhuajiang Pharmaceutical Limited (HSPL), a Chinese state-owned pharmaceutical company. The company entered into a ...
Hazards of surgery and anesthesia for drug, alcohol abusers presented at meeting.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Substance abusers who think it's okay not to tell their oral and maxillofacial surgeon about their drug use are putting themselves at risk for surgical complications, even if they're having a procedure as relatively straightforward as a wisdom ...
Guidelines offer new recommendations for travelers.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- New antithrombotic guidelines from the American College of Chest Physicians (ACCP) introduce novel therapies for the prevention and treatment of thrombosis and, for the first time, offer specific recommendations for long-distance travelers. ...
Outline provided for developing national clinical trials registry.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- For the first time since announcing its support of a national clinical trials registry, the American Medical Association outlined to Congress key criteria needed to make such a registry effective. "Physicians need complete and unbiased ...
Pharmaceutical company obtains an unsecured $100M credit facility.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners, Inc., (APPX) announced that it has established a $100 million unsecured, 3-year, senior revolving credit facility. The new facility, expandable to $150 million, replaces an existing, 5-year, senior ...
Excimer lasers safe, effective for pediatric eye maladies, study shows.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- The first study to document the safety and effectiveness of the use of excimer lasers to treat a variety of eye maladies in children was published in the September edition of the Journal of Cataract & Refractive Surgery. The primary ...
New statement published on nonmalignant diseases related to asbestos exposure.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- In its first official statement since 1986 on the topic, the American Thoracic Society (ATS) has published a document entitled Diagnosis and Initial Management of Nonmalignant Diseases Related to Asbestos. The revised statement, updated ...
HGV transmitted efficiently via the sexual route.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Hepatitis G virus is transmitted efficiently via the sexual route. According to a study from Lebanon, "The importance of sexual transmission in the epidemiology of hepatitis G virus (HGV) and hepatitis C virus (HCV) was evaluated in two ...
Biotech demerger completed, key appointments reported.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Amrad Corporation Limited (AML) announced successful completion of the final steps in the demerger and spin-out of its anti-infectives business, Avexa Limited. Having obtained shareholder approval on August 31, federal court approval of ...
Pharmaceutical companies sign drug discovery deal.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Anadys Pharmaceuticals, Inc., (ANDS) and Aphoenix, Inc., an emerging chemical genomics company in Japan, announced that they have entered into a 3-year drug discovery collaboration. Under the terms of the agreement, Anadys will utilize ...
Device company forms scientific advisory board.
Oct 06, 2004 ... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Andromed, Inc., (AD) has formed a scientific advisory board consisting of four clinicians: Richard Hughes, Joseph V. Messer, Edward S. Ogata and Hans Pasterkamp. This high-caliber scientific advisory board will provide clinical and ...